Identification and characterization of adverse drug reactions in patients with all – a preliminary study
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Poster
- By: JOAQUIM, João (Coimbra Health School, Pharmacy, Coimbra, Portugal)
- Co-author(s): Matos, Cristiano (Coimbra Health School, Coimbra, Portugal)
Marquês, Filipa (Coimbra Health School, Coimbra, Portugal)
Pires, Timóteo (Coimbra Health School, Coimbra, Portugal)
Introduction Adverse drug reactions (ADRs) are a substantial cause of morbidity and mortality worldwide. These events are commonly related to the usage of antineoplastic drugs. The cytarabine (Ara-C) is an antineoplastic drug that is administrated in acute lymphoblastic leukemia (ALL) protocols as Linker Protocol and it can originate severe.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.